The Chemokine Receptor CCR5, a Therapeutic Target for HIV/AIDS Antagonists, Is Critical for Recovery in a Mouse Model of Japanese Encephalitis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Larena, Maximilian ^a   Regner, Matthias ^a   Lobigs, Mario ^a,b  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTAGONIST;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOSTIMULATION; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LEUKOCYTE ACTIVATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MORTALITY; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SPLEEN CELL; SURVIVAL; VIRUS CELL INTERACTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; ENCEPHALITIS, JAPANESE; FEMALE; HIV INFECTIONS; IMMUNITY, HUMORAL; KILLER CELLS, NATURAL; MICE; MOLECULAR TARGETED THERAPY; RECEPTORS, CCR5; SPLEEN; SURVIVAL ANALYSIS; VERO CELLS;

FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; MUS;

EID: 84866687356     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044834     Document Type: Article

References (61)

1. Allen SJ, Crown SE, Handel TM, (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25: 787-820.
2. Sorce S, Myburgh R, Krause KH, (2011) The chemokine receptor CCR5 in the central nervous system. Prog Neurobiol 93: 297-311.
3. Alkhatib G, (2009) The biology of CCR5 and CXCR4. Curr Opin HIV AIDS 4: 96-103.
4. Wilkin TJ, Gulick RM, (2012) CCR5 Antagonism in HIV Infection: Current Concepts and Future Opportunities. Annu Rev Med 63: 15.11-15.13.
5. Klein RS, (2008) A moving target: the multiple roles of CCR5 in infectious diseases. J Infect Dis 197: 183-186.
6. Lim JK, Glass WG, McDermott DH, Murphy PM, (2006) CCR5: no longer a "good for nothing" gene-chemokine control of West Nile virus infection. Trends Immunol 27: 308-312.
7. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, et al. (2005) Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202: 1087-1098.
8. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, et al. (2006) CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203: 35-40.
9. Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, et al. (2010) CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis 201: 178-185.
10. Kindberg E, Mickiene A, Ax C, Akerlind B, Vene S, et al. (2008) A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis 197: 266-269.
11. Pulendran B, Miller J, Querec TD, Akondy R, Moseley N, et al. (2008) Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis 198: 500-507.
12. Gould EA, Solomon T, (2008) Pathogenic flaviviruses. Lancet 371: 500-509.
13. Solomon T, (2004) Flavivirus encephalitis. N Engl J Med 351: 370-378.
14. Halstead SB, Jacobson J, (2003) Japanese encephalitis. Adv Virus Res 61: 103-138.
15. Larena M, Lobigs M (2011) Immunobiology of Japanese Encephalitis Virus, Flavivirus Encephalitis, Daniel Růžek, editors. ISBN: 978-953-307-669-0, InTech. Available: http://www.intechopen.com/articles/show/title/immunobiology-of-japanese-encephalitis-virus.
16. Larena M, Regner M, Lee E, Lobigs M, (2011) Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis. J Virol 85: 5446-5455.
17. Lee E, Lobigs M, (2002) Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76: 4901-4911.
18. Kiessling R, Klein E, Wigzell H, (1975) "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5: 112-117.
19. Licon Luna RM, Lee E, Mullbacher A, Blanden RV, Langman R, et al. (2002) Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice. J Virol 76: 3202-3211.
20. Kuziel WA, Dawson TC, Quinones M, Garavito E, Chenaux G, et al. (2003) CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 167: 25-32.
21. Lee E, Hall RA, Lobigs M, (2004) Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J Virol 78: 8271-8280.
22. Tscharke DC, Karupiah G, Zhou J, Palmore T, Irvine KR, et al. (2005) Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201: 95-104.
23. Momburg F, Mullbacher A, Lobigs M, (2001) Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J Virol 75: 5663-5671.
24. Colombage G, Hall R, Pavy M, Lobigs M, (1998) DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology 250: 151-163.
25. Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, et al. (2010) An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses. J Gen Virol 91: 1407-1417.
26. Kesson AM, Blanden RV, Mullbacher A, (1987) The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile. J Gen Virol 68 (Pt 7):: 2001-2006.
27. Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, et al. (2007) Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 37: 1845-1854.
28. Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, et al. (2006) The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74: 135-143.
29. Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, et al. (2006) CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog 2: 484-500.
30. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N, (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156: 1951-1959.
31. Fadel SA, Bromley SK, Medoff BD, Luster AD, (2008) CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality. Eur J Immunol 38: 3376-3387.
32. Kohlmeier JE, Miller SC, Smith J, Lu B, Gerard C, et al. (2008) The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 29: 101-113.
33. Thapa M, Kuziel WA, Carr DJ, (2007) Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 81: 3704-3713.
34. Olive AJ, Gondek DC, Starnbach MN, (2011) CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa. Mucosal Immunol 4: 208-216.
35. Algood HM, Flynn JL, (2004) CCR5-deficient mice control Mycobacterium tuberculosis infection despite increased pulmonary lymphocytic infiltration. J Immunol 173: 3287-3296.
36. Ank N, Petersen K, Malmgaard L, Mogensen SC, Paludan SR, (2005) Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2. J Virol 79: 9831-9841.
37. Nansen A, Christensen JP, Andreasen SO, Bartholdy C, Christensen JE, et al. (2002) The role of CC chemokine receptor 5 in antiviral immunity. Blood 99: 1237-1245.
38. Peterson KE, Errett JS, Wei T, Dimcheff DE, Ransohoff R, et al. (2004) MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis. Journal of virology 78: 6449-6458.
39. Zhong MX, Kuziel WA, Pamer EG, Serbina NV, (2004) Chemokine receptor 5 is dispensable for innate and adaptive immune responses to Listeria monocytogenes infection. Infection and immunity 72: 1057-1064.
40. Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, et al. (2000) CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nat Immunol 1: 83-87.
41. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, et al. (2006) Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440: 890-895.
42. Hickman HD, Li L, Reynoso GV, Rubin EJ, Skon CN, et al. (2011) Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. J Exp Med 208: 2511-2524.
43. Hugues S, Scholer A, Boissonnas A, Nussbaum A, Combadiere C, et al. (2007) Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses. Nat Immunol 8: 921-930.
44. Floto RA, MacAry PA, Boname JM, Mien TS, Kampmann B, et al. (2006) Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science 314: 454-458.
45. Kohlmeier JE, Reiley WW, Perona-Wright G, Freeman ML, Yager EJ, et al. (2011) Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection. J Exp Med 208: 1621-1634.
46. Belnoue E, Kayibanda M, Deschemin JC, Viguier M, Mack M, et al. (2003) CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 101: 4253-4259.
47. Souza AL, Souza PR, Pereira CA, Fernandes A, Guabiraba R, et al. (2011) Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation. Infect Immun 79: 1741-1749.
48. Sato N, Kuziel WA, Melby PC, Reddick RL, Kostecki V, et al. (1999) Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. J Immunol 163: 5519-5525.
49. Huffnagle GB, McNeil LK, McDonald RA, Murphy JW, Toews GB, et al. (1999) Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol 163: 4642-4646.
50. Komatsu K, Miyazaki D, Morohoshi K, Kuo CH, Kakimaru-Hasegawa A, et al. (2008) Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice. Curr Eye Res 33: 736-749.
51. Glass WG, Lane TE, (2003) Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease. J Virol 77: 191-198.
52. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, et al. (2009) Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206: 1273-1289.
53. Weiss ID, Shoham H, Wald O, Wald H, Beider K, et al. (2011) Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions. Cytokine 54: 249-257.
54. Lobigs M, Blanden RV, Mullbacher A, (1996) Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. Immunol Rev 152: 5-19.
55. Kesson AM, King NJ, (2001) Transcriptional regulation of major histocompatibility complex class I by flavivirus West Nile is dependent on NF-kappaB activation. J Infect Dis 184: 947-954.
56. King NJ, Kesson AM, (1988) Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection. J Gen Virol 69 (Pt 10):: 2535-2543.
57. Lobigs M, Mullbacher A, Regner M, (2003) MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen. Immunol Cell Biol 81: 217-223.
58. Mullbacher A, Lobigs M, (1995) Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity 3: 207-214.
59. Shrestha B, Samuel MA, Diamond MS, (2006) CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol 80: 119-129.
60. Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K, (2009) Past, present, and future of Japanese encephalitis. Emerg Infect Dis 15: 1-7.
61. Simon V, Ho DD, Abdool Karim Q, (2006) HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 368: 489-504.